Keep Informed on Legal and Compliance Developments Affecting Diagnostic Labs
Best practices and expert insight to help lab professionals comply with regulations and identify strategic trends in business and technology
Already a Subscriber? Log in Here
Lab Industry Advisor Subscription
Struggling with Staying Informed? In the fast-paced world of diagnostic medicine, staying updated with the latest legal, compliance, regulatory, and industry insights is crucial. Yet, finding reliable and comprehensive information can be overwhelming and time-consuming.
Lab Industry Advisor to the Rescue! Lab Industry Advisor provides comprehensive, up-to-date insights and analyses tailored to your needs. With expert commentary and actionable advice, you’ll stay ahead of the curve. No more sifting through endless sources—everything you need is right here!
Start your free trial today and see how Lab Industry Advisor can transform your approach. Get instant access to invaluable resources designed to keep you informed and competitive. Explore detailed reports, in-depth articles, and exclusive industry insights that help you make better decisions faster. Choose from three subscription levels tailored to fit your needs: Essential, Premium, and Elite.
Additional Business Intelligence Offerings
Clinical Diagnostics Insider
Keeps you up-to-date on new diagnostic tests, testing trends and opportunities, and emerging test technologies
Virtual Events & Webinars
Virtual events & webinars offer a variety of solutions and strategies for dealing with key issues labs face.
Lab Industry Advisor Subscriptions Include
Analysis and insight on key compliance, legal, and business developments affecting laboratories
- Updates on changes to regulations
- Healthcare-related laws
- FDA approvals
- Business deals in the diagnostics space, and more
Latest Articles
LDTs Rule Update: More Support for Legal Challenges Against FDA
Key clinical laboratory organizations file amicus brief, reiterating that the FDA is overstepping its authority, and its new rule would cause “irreparable patient harm”
New FDA LDTs Guidance Offers Useful Summary, But Questions Remain
Recently released document for small labs offers a more digestible version of the final rule requirements but still lacks key details
CMS Slated to Close Change Healthcare Payment Program
Program meant to ease cash flow disruptions experienced by some Medicare providers and suppliers due to the cyberattack will conclude in mid-July
Special Report: 5 Lab Kickback Risks Involving Incentives
Strategies to avoid compliance issues related to registries, space rentals, and other common incentives.
Boosting Retention and Hiring in Medical Laboratories
Key reasons for continued staffing shortages and tips for addressing these issues to support current staff and attract new talent.
We’ve Lost Our Lab Director, Now What?
Key steps to successfully navigate a CLIA laboratory director transition and select the best possible replacement for your organization.
Tool: Guide for Assessing Lab Director Candidates
Key areas to address when reviewing CLIA lab director applicants and developing interview questions.
Expert Q&A: Key Issues and Developments in Clinical Lab Automation
Laboratory leaders from Geisinger discuss key lab automation developments in their organization.
The Benefits of Penetration Tests in Labs
Cybersecurity expert explains the importance of such assessments, which simulate malicious attacks to identify IT vulnerabilities.
Automating Your Clinical Laboratory
How clinical laboratories can get started in automation—and what to consider when doing so.
Expert Q&A: Clinical Lab Automation Trends and Tips for Implementation
Laboratory leader Ihab Abumuhor discusses recent lab automation-related developments and the keys to successful implementation.
Challenges and Opportunities in Lab Automation
As technology advances and testing demand grows, automation and AI are increasingly making their way into the clinical lab.
March 2024 Labs in Court
Recent cases involve another fraud related to finger prick blood testing, as well as alleged malpractice and discrimination.
